Es gab 50 kürzliche Insider-Transaktionen für Cullinan Therapeutics, Inc. (CGEM), darunter 22 Käufe und 25 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $36.66M und die gesamten Insider-Verkäufe auf $1.4M.
Bedeutende Insider mit kürzlicher Aktivität umfassen Michaelson Jennifer, Ahmed Nadim, Sumer Jacquelyn L. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — CGEM
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2026-03-05 |
Michaelson Jennifer |
Chief Scientific Officer |
Optionsausübung (Verkauf) |
4,000 |
$4.30 |
$17.2K |
120,987 |
| 2026-02-25 |
Michaelson Jennifer |
Chief Scientific Officer |
Informierter Verkauf |
1,780 |
$14.14 |
$25.17K |
174,844 |
| 2026-02-24 |
Ahmed Nadim |
President and CEO |
Informierter Verkauf |
13,515 |
$14.47 |
$195.56K |
390,803 |
| 2026-02-24 |
Michaelson Jennifer |
Chief Scientific Officer |
Informierter Verkauf |
3,601 |
$14.47 |
$52.11K |
176,624 |
| 2026-02-24 |
Sumer Jacquelyn L |
Chief Legal Officer |
Informierter Verkauf |
3,601 |
$14.47 |
$52.11K |
128,089 |
| 2026-02-24 |
Jones Jeffrey Alan |
Chief Medical Officer |
Informierter Verkauf |
4,582 |
$14.47 |
$66.3K |
159,968 |
| 2026-02-23 |
Michaelson Jennifer |
Chief Scientific Officer |
Informierter Verkauf |
1,752 |
$13.99 |
$24.51K |
180,225 |
| 2026-02-20 |
Fenton Mary Kay |
Chief Financial Officer |
Informierter Verkauf |
4,398 |
$13.62 |
$59.9K |
126,380 |
| 2026-02-20 |
Ahmed Nadim |
President and CEO |
Informierter Verkauf |
16,381 |
$13.62 |
$223.11K |
404,318 |
| 2026-02-20 |
Michaelson Jennifer |
Chief Scientific Officer |
Optionsausübung (Verkauf) |
8,000 |
$4.30 |
$34.4K |
124,987 |
| 2026-02-20 |
Sumer Jacquelyn L |
Chief Legal Officer |
Informierter Verkauf |
3,742 |
$13.62 |
$50.97K |
131,690 |
| 2026-02-20 |
Jones Jeffrey Alan |
Chief Medical Officer |
Informierter Verkauf |
4,982 |
$13.62 |
$67.85K |
164,550 |
| 2026-02-18 |
Fenton Mary Kay |
Chief Financial Officer |
RSU-Zuteilung |
68,750 |
- |
- |
130,778 |
| 2026-02-18 |
Ahmed Nadim |
President and CEO |
RSU-Zuteilung |
828,000 |
$12.44 |
$10.3M |
828,000 |
| 2026-02-18 |
Savill Corrine |
Chief Business Officer |
RSU-Zuteilung |
175,000 |
$12.44 |
$2.18M |
175,000 |
| 2026-02-18 |
Michaelson Jennifer |
Chief Scientific Officer |
RSU-Zuteilung |
115,000 |
$12.44 |
$1.43M |
115,000 |
| 2026-02-18 |
Sumer Jacquelyn L |
Chief Legal Officer |
RSU-Zuteilung |
230,000 |
$12.44 |
$2.86M |
230,000 |
| 2026-02-18 |
Jones Jeffrey Alan |
Chief Medical Officer |
RSU-Zuteilung |
300,000 |
$12.44 |
$3.73M |
300,000 |
| 2026-02-12 |
Michaelson Jennifer |
Chief Scientific Officer |
Informierter Verkauf |
416 |
$12.03 |
$5K |
128,219 |
| 2026-01-22 |
Michaelson Jennifer |
Chief Scientific Officer |
Informierter Verkauf |
4,000 |
$12.30 |
$49.2K |
128,635 |
| 2025-12-31 |
Fenton Mary Kay |
Chief Financial Officer |
RSU-Zuteilung |
27 |
$6.49 |
$175.23 |
62,028 |
| 2025-12-23 |
Ahmed Nadim |
President and CEO |
Informierter Verkauf |
9,922 |
$10.01 |
$99.32K |
420,699 |
| 2025-12-19 |
Michaelson Jennifer |
Chief Scientific Officer |
Informierter Verkauf |
1,345 |
$10.01 |
$13.46K |
132,635 |
| 2025-12-18 |
Michaelson Jennifer |
Chief Scientific Officer |
Informierter Verkauf |
2,898 |
$9.67 |
$28.02K |
133,980 |
| 2025-12-18 |
Sumer Jacquelyn L |
Chief Legal Officer |
Informierter Verkauf |
3,480 |
$9.67 |
$33.65K |
135,432 |
| 2025-12-18 |
Jones Jeffrey Alan |
Chief Medical Officer |
Informierter Verkauf |
4,632 |
$9.67 |
$44.79K |
169,532 |
| 2025-12-15 |
Michaelson Jennifer |
Chief Scientific Officer |
Informierter Verkauf |
995 |
$11.90 |
$11.84K |
136,878 |
| 2025-12-12 |
Michaelson Jennifer |
Chief Scientific Officer |
Informierter Verkauf |
2,148 |
$12.38 |
$26.59K |
137,873 |
| 2025-11-24 |
Michaelson Jennifer |
Chief Scientific Officer |
Informierter Verkauf |
4,000 |
$12.30 |
$49.2K |
138,004 |
| 2025-10-28 |
Lynx1 Capital Management Lp |
10 Percent Owner |
Informierter Kauf |
165,667 |
$8.40 |
$1.39M |
8,963,500 |
| 2025-10-17 |
Lynx1 Capital Management Lp |
10 Percent Owner |
Informierter Kauf |
32,217 |
$7.84 |
$252.57K |
8,797,833 |
| 2025-10-16 |
Lynx1 Capital Management Lp |
10 Percent Owner |
Informierter Kauf |
150,000 |
$8.86 |
$1.33M |
8,765,616 |
| 2025-10-15 |
Lynx1 Capital Management Lp |
10 Percent Owner |
Informierter Kauf |
51,500 |
$7.94 |
$409.05K |
8,615,616 |
| 2025-10-14 |
Lynx1 Capital Management Lp |
10 Percent Owner |
Informierter Kauf |
15,032 |
$7.59 |
$114.05K |
8,564,116 |
| 2025-10-10 |
Lynx1 Capital Management Lp |
10 Percent Owner |
Informierter Kauf |
277,298 |
$7.36 |
$2.04M |
8,549,084 |
| 2025-10-09 |
Lynx1 Capital Management Lp |
10 Percent Owner |
Informierter Kauf |
626,043 |
$6.70 |
$4.19M |
8,271,786 |
| 2025-10-08 |
Lynx1 Capital Management Lp |
10 Percent Owner |
Unbekannt |
- |
- |
- |
7,089,443 |
| 2025-10-08 |
Lynx1 Capital Management Lp |
10 Percent Owner |
Informierter Kauf |
556,300 |
$6.46 |
$3.59M |
7,645,743 |
| 2025-08-07 |
Allen Andrew R |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2025-08-07 |
Allen Andrew R |
Director |
RSU-Zuteilung |
79,456 |
$7.03 |
$558.58K |
79,456 |
| 2025-08-07 |
Doyle Mittie |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2025-08-07 |
Doyle Mittie |
Director |
RSU-Zuteilung |
79,456 |
$7.03 |
$558.58K |
79,456 |
| 2025-06-12 |
Webster Stephen W |
Director |
RSU-Zuteilung |
38,513 |
$8.95 |
$344.69K |
38,513 |
| 2025-06-12 |
Rosenberg Anthony |
Director |
RSU-Zuteilung |
38,513 |
$8.95 |
$344.69K |
38,513 |
| 2025-06-12 |
Meek David D. |
Director |
RSU-Zuteilung |
38,513 |
$8.95 |
$344.69K |
38,513 |
| 2025-06-12 |
Martin Anne-marie |
Director |
RSU-Zuteilung |
38,513 |
$8.95 |
$344.69K |
38,513 |
| 2025-06-12 |
Ryan David P. |
Director |
RSU-Zuteilung |
38,513 |
$8.95 |
$344.69K |
38,513 |
| 2025-02-25 |
Ahmed Nadim |
President and CEO |
Informierter Verkauf |
12,529 |
$8.53 |
$106.87K |
430,621 |
| 2025-02-25 |
Michaelson Jennifer |
Chief Scientific Officer |
Informierter Verkauf |
3,756 |
$8.53 |
$32.04K |
142,004 |
| 2025-02-25 |
Sumer Jacquelyn L |
Chief Legal Officer |
Informierter Verkauf |
3,756 |
$8.53 |
$32.04K |
136,895 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
